Kinex Pharmaceuticals Secures $300,000 New Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9ed33f54-130f-4555-9051-5f0b427ad59a
Date
12/23/2013
Company Name
Kinex Pharmaceuticals
Mailing Address
701 Ellicott Street Buffalo, NY 14203
Company Description
Kinex is a specialty pharmaceutical company focused on the development and commercialization of next generation therapies for cancer and immunomodulatory diseases.
Website
http://www.kinexpharma.com
Transaction Type
Venture Equity
Transaction Amount
$300,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
M&A Terms
Venture Investor
Undisclosed